204 related articles for article (PubMed ID: 29315564)
1. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.
Ge W; Clendenen TV; Afanasyeva Y; Koenig KL; Agnoli C; Brinton LA; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
Int J Cancer; 2018 Jun; 142(11):2215-2226. PubMed ID: 29315564
[TBL] [Abstract][Full Text] [Related]
2. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk.
Nichols HB; Baird DD; Stanczyk FZ; Steiner AZ; Troester MA; Whitworth KW; Sandler DP
Cancer Prev Res (Phila); 2015 Jun; 8(6):528-34. PubMed ID: 25873369
[TBL] [Abstract][Full Text] [Related]
4. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
[TBL] [Abstract][Full Text] [Related]
5. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
6. Fat intake and its relationship with pre- and post-menopausal breast cancer risk: a case-control study in Malaysia.
Sulaiman S; Shahril MR; Shaharudin SH; Emran NA; Muhammad R; Ismail F; Husain SN
Asian Pac J Cancer Prev; 2011; 12(9):2167-78. PubMed ID: 22296351
[TBL] [Abstract][Full Text] [Related]
7. Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort.
Amadou A; Praud D; Coudon T; Danjou AMN; Faure E; Leffondré K; Le Romancer M; Severi G; Salizzoni P; Mancini FR; Fervers B
Int J Cancer; 2020 Jan; 146(2):341-351. PubMed ID: 30851122
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic circulating anti-Müllerian hormone concentrations are not associated with prostate cancer risk.
Sklavos MM; Zhou CK; Pinto LA; Cook MB
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2597-602. PubMed ID: 25159294
[TBL] [Abstract][Full Text] [Related]
9. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
Kühn T; Kaaks R; Becker S; Eomois PP; Clavel-Chapelon F; Kvaskoff M; Dossus L; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Lukanova A; Buijsse B; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Krogh V; Sacerdote C; Tumino R; Mattiello A; Buckland G; Sánchez MJ; Menéndez V; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; van Duijnhoven FJ; van Gils CH; Bakker MF; Weiderpass E; Skeie G; Brustad M; Andersson A; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Rinaldi S; Romieu I; Gallo V; Murphy N; Riboli E; Linseisen J
Int J Cancer; 2013 Oct; 133(7):1689-700. PubMed ID: 23526380
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Bertone-Johnson E; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4542-e4553. PubMed ID: 34157104
[TBL] [Abstract][Full Text] [Related]
13. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
14. Anti-Mullerian hormone and risk of invasive serous ovarian cancer.
Schock H; Lundin E; Vääräsmäki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
Cancer Causes Control; 2014 May; 25(5):583-9. PubMed ID: 24562905
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
Kaaks R; Johnson T; Tikk K; Sookthai D; Tjønneland A; Roswall N; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Dossus L; Rinaldi S; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Tumino R; Sacerdote C; Panico S; Buckland G; Argüelles M; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Gram IT; Lund E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
Int J Cancer; 2014 Jun; 134(11):2683-90. PubMed ID: 24248481
[TBL] [Abstract][Full Text] [Related]
16. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
17. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Steiner AZ; Eliassen AH; Hankinson SE; Rosner BA; Whitcomb BW
Hum Reprod; 2018 Jun; 33(6):1175-1182. PubMed ID: 29659835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
